Broderick Brian C Has $12.57 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Broderick Brian C grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,497 shares of the healthcare conglomerate’s stock after purchasing an additional 100 shares during the period. UnitedHealth Group comprises about 2.5% of Broderick Brian C’s holdings, making the stock its 19th largest position. Broderick Brian C’s holdings in UnitedHealth Group were worth $12,569,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in UNH. Oak Harbor Wealth Partners LLC lifted its stake in UnitedHealth Group by 7.4% in the third quarter. Oak Harbor Wealth Partners LLC now owns 1,869 shares of the healthcare conglomerate’s stock valued at $1,093,000 after acquiring an additional 128 shares during the last quarter. Sargent Investment Group LLC boosted its holdings in UnitedHealth Group by 22.4% in the third quarter. Sargent Investment Group LLC now owns 4,735 shares of the healthcare conglomerate’s stock worth $2,768,000 after purchasing an additional 867 shares in the last quarter. Omnia Family Wealth LLC raised its holdings in UnitedHealth Group by 14.3% during the third quarter. Omnia Family Wealth LLC now owns 894 shares of the healthcare conglomerate’s stock valued at $523,000 after buying an additional 112 shares in the last quarter. Nicola Wealth Management LTD. boosted its stake in shares of UnitedHealth Group by 19.7% during the 3rd quarter. Nicola Wealth Management LTD. now owns 36,400 shares of the healthcare conglomerate’s stock worth $21,282,000 after acquiring an additional 6,000 shares in the last quarter. Finally, Lifeworks Advisors LLC lifted its holdings in UnitedHealth Group by 21.4% in the 3rd quarter. Lifeworks Advisors LLC now owns 1,446 shares of the healthcare conglomerate’s stock worth $845,000 after purchasing an additional 255 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Truist Financial reissued a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Finally, UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $593.30 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a fifty day moving average price of $582.99 and a two-hundred day moving average price of $548.03. The firm has a market capitalization of $546.00 billion, a P/E ratio of 38.65, a P/E/G ratio of 1.78 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.56 earnings per share. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.